image269

Mapped: The World’s Top 10 Cities in 2035

Published 2 days ago on October 18, 2019By Iman Ghosh

 

Mapped: Where Will The Top 10 Cities Be in 2035?


 

Top 10 Cities by Projected GDP


 

Top 10 Cities by Future Population

 

 

Top 10 Cities By Estimated Annual GDP Growth


 https://www.visualcapitalist.com/top-10-cities/ 

Mapped: The World’s Top 10 Cities in 2035Published 2 days ago on October 18, 2019By Iman Ghosh

 

Mapped: The World’s Top 10 Cities in 2035

Published 2 days ago on October 18, 2019

By


 

https://www.visualcapitalist.com/top-10-cities/ 


 

Weighing The Week Ahead: Earnings Season Opportunities

Oct. 20, 2019 6:55 AM ET|28 comments  | Includes: BAPR, BAUG, BIBL, BJUL, BJUN, BOCT, CHGX, CRF, DDM, DIA, DMRL, DOG, DUSA, DXD, EDOW, EEH, EPS, EQL, EQWL, ESGL, FEX, FWDD, GSEW, HUSV, IVV, IWL, IWM, JHML, JKD, OMFS, OTPIX, PAPR, PAUG, PJAN, PJUN, PMOM, PPLC, PSQ, QID, QLD, QQEW, QQQ, QQQE, QQXT, RSP, RVRS, RWL, RWM, RWSL, RYARX, RYRSX, SCAP, SCHX, SDOW, SDS, SFLA, SFY, SH, SMLL, SPDN, SPLX, SPSM, SPUU, SPXE, SPXL, SPXN, SPXS, SPXT, SPXU, SPXV, SPY, SQQQ, SRTY, SSO, SSPY, SYE, TNA, TQQQ, TRND, TWM, TZA, UAUG, UDOW, UDPIX, UJAN, UOCT, UPRO, URTY, USA, USMC, UWM, VFINX, VOO, VTWO, VV, ZFJeff MillerValue, Growth 


 https://seekingalpha.com/article/4297479-weighing-week-ahead-earnings-season-opportunities 

2019 Q3 - Results

Intercept Pharmaceuticals, Inc. (ICPT)

image270

 

Intercept Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 11:26 AM ET | About: Intercept Pharmaceuticals, Inc. (ICPT) 

Neurocrine Biosciences, Inc. (NBIX)

image271

 

Neurocrine Biosciences, Inc. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 7:48 AM ET | About: Neurocrine Biosciences, Inc. (NBIX) 

: Amarin Corporation plc (AMRN)

image272

 

Amarin Corporation plc 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 3:32 PM ET  | About: Amarin Corporation plc (AMRN) 

Becton, Dickinson and Company (BDX)

image273

 

Becton, Dickinson and Company 2019 Q4 - Results - Earnings Call Presentation

Nov. 5, 2019 3:32 PM ET|1 comment | About: Becton, Dickinson and Company (BDX) 

QIAGEN N.V. (QGEN)

image274

 

QIAGEN N.V. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 2:28 PM ET | About: QIAGEN N.V. (QGEN) 

IN.PACT™ Admiral™ DCB

image275

 

Four-Year Data from the IN.PACT Global Study Highlight Durable Performance and Safety of IN.PACT™ Admiral™ DCB

Tue November 5, 2019 1:15 PM|GlobeNewswire|About: MDT

Longest-Term Data from a Real-World PAD Patient Population Presented at VIVA

DUBLIN and LAS VEGAS, Nov. 05, 2019 (GLOBE NEWSWIRE) --  Medtronic plc (MDT)

2019 Q3 - Results

Celgene Corporation (CELG)

image276

 

Celgene Corporation 2019 Q3 - Results - Earnings Call Presentation

Nov. 1, 2019 11:58 AM ET|5 comments | About: Celgene Corporation (CELG) 

Exelixis, Inc. (EXEL)

image277

 

Exelixis, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 3:51 PM ET|1 comment | About: Exelixis, Inc. (EXEL) 

Sanofi (SNY)

image278

 

Sanofi 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 1:57 PM ET | About: Sanofi (SNY) 

bluebird bio, Inc. (BLUE)

image279

 

bluebird bio (BLUE) Investor Presentation - Slideshow

Nov. 2, 2019 2:03 PM ET|1 comment | About: bluebird bio, Inc. (BLUE) 

GlaxoSmithKline plc (GSK)

image280

 

GlaxoSmithKline plc 2019 Q3 - Results - Earnings Call Presentation

Oct. 30, 2019 10:13 AM ET | About: GlaxoSmithKline plc (GSK) 

Vertex Pharmaceuticals Incorporated (VRTX)

image281

 

Vertex Pharmaceuticals Incorporated 2019 Q3 - Results - Earnings Call Presentation

Nov. 3, 2019 10:53 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX) 

2019 Q3 - Results

Merck & Co., Inc. (MRK)

image282

 

Merck & Co., Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 8:34 AM ET | About: Merck & Co., Inc. (MRK) 



Pfizer Inc. (PFE)

image283

 

Pfizer Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 7:26 AM ET  | About: Pfizer Inc. (PFE) 



Incyte Corporation (INCY)

 

Incyte Corporation 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 9:32 AM ET | About: Incyte Corporation (INCY) 



Amgen Inc. (AMGN)

image284

 

Amgen Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 4:59 PM ET | About: Amgen Inc. (AMGN) 

NovoCure Limited (NVCR)

image285

NovoCure Limited 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 12:28 PM ET  | About: NovoCure Limited (NVCR) 

Seattle Genetics, Inc. (SGEN)

image286

 

Seattle Genetics, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 8:04 PM ET | About: Seattle Genetics, Inc. (SGEN) 

2019 Q3 - Results

Novartis AG (NVS)

image287

 

Novartis AG 2019 Q3 - Results - Earnings Call Presentation

Oct. 22, 2019 6:53 AM ET | About: Novartis AG (NVS) 

Novartis AG (NVS)

image288

 

Novartis AG 2019 Q3 - Results - Earnings Call Presentation

Oct. 22, 2019 6:53 AM ET | About: Novartis AG (NVS) 

Amarin Corporation plc (AMRN)

image289

 

Amarin Corporation (AMRN) Investor Presentation - Slideshow

Oct. 3, 2019 10:59 AM ET|11 comments  | About: Amarin Corporation plc (AMRN) 

AstraZeneca PLC (AZN)

image290

 

AstraZeneca PLC 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 10:19 AM ET | About: AstraZeneca PLC (AZN) 



Gilead Sciences, Inc. (GILD)

image291

 

Gilead Sciences, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 4:31 PM ET|1 comment  | About: Gilead Sciences, Inc. (GILD) 

Illumina, Inc. (ILMN)

image292

 

Illumina, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 6:25 PM ET|2 comments | About: Illumina, Inc. (ILMN) 

2019 Q3 - Results

Boston Scientific Corporation (BSX)

image293

 

Boston Scientific Corporation 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 8:21 AM ET | About: Boston Scientific Corporation (BSX) 

Alkermes plc (ALKS)

image294

 

Alkermes plc 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 7:57 AM ET | About: Alkermes plc (ALKS) 

About: Alexion Pharmaceuticals, Inc. (ALXN)

image295

 

Alexion Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 9:59 AM ET | About: Alexion Pharmaceuticals, Inc. (ALXN) 

Veracyte, Inc. (VCYT)

image296

 

Veracyte, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 12:37 AM ET | About: Veracyte, Inc. (VCYT) 

Eli Lilly and Company (LLY)

image297

 

Eli Lilly and Company 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 10:01 AM ET | About: Eli Lilly and Company (LLY) 

Biogen Inc. (BIIB)

image298

 

Biogen Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 22, 2019 7:13 AM ET  | About: Biogen Inc. (BIIB) 

BAC Global HealthCare Conference & ESMO Congress 2019

Incyte Corporation (INCY)

image299

 

Incyte Corporation (INCY) Presents At Bank of America Merrill Lynch Global Healthcare Conference - Slideshow

Sep. 19, 2019 10:11 AM ET | About: Incyte Corporation (INCY) 

About: Amgen Inc. (AMGN)

image300

 

Amgen Inc. (AMGN) Management Presents at The Bank of America Merrill Lynch Global Healthcare Conference (Transcript)

Sep. 18, 2019 9:01 AM ET | About: Amgen Inc. (AMGN) 

Amgen Inc. (AMGN)

image301

 

Amgen (AMGN) Presents At ESMO Congress 2019 - Slideshow

Oct. 2, 2019 12:20 PM ET | About: Amgen Inc. (AMGN) 

: Novartis AG (NVS)

image302

 

Novartis AG (NVS) Updates on Kisqali® MONALEESA-3 ESMO Data - Slideshow

Oct. 1, 2019 1:15 PM ET | About: Novartis AG (NVS) 

Bristol-Myers Squibb Company (BMY)

image303

Bristol-Myers Squibb (BMY) Presents At ESMO Congress 2019 - Slideshow

Sep. 30, 2019 3:34 PM ET | About: Bristol-Myers Squibb Company (BMY) 

AstraZeneca PLC (AZN)

image304

 

AstraZeneca Group (AZN) Presents At ESMO Congress 2019 - Slideshow

Oct. 2, 2019 12:06 PM ET | About: AstraZeneca PLC (AZN) 

Wainwright 21st Annual Global Investment Conference

CytoDyn (CYDY)

image305

 

CytoDyn (CYDY) Investor Presentation - Slideshow

Sep. 16, 2019 12:51 PM ET | About: CytoDyn Inc. (CYDY) 

Sesen Bio, Inc. (SESN)

image306

 

Sesen Bio (SESN) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow

Sep. 16, 2019 1:51 PM ET | About: Sesen Bio, Inc. (SESN) 

GW Pharmaceuticals plc (GWPH)

image307

 

GW Pharmaceuticals (GWPH) Investor Presentation - Slideshow

Sep. 16, 2019 1:53 PM ET | About: GW Pharmaceuticals plc (GWPH) 

ProBeam 360 Proton Therapy System

image308

 

Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System

Mon September 16, 2019 8:00 AM|PR Newswire|About: VAR

PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (VSEA) (NYSE: VAR)

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

image309

 

BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia

Mon September 16, 2019 6:30 AM|GlobeNewswire|About: BCTXF, INCY, MRK

BERKELEY, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (BCTXF) ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF)

VCF Care Pathway

image310

 

National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)

Mon September 16, 2019 10:00 AM|GlobeNewswire|About: MDTGlobeNewswire

DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (MDT)

earnings Call Slides Q2./HY 2019

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

image311

 

Novo Nordisk A/S 2019 Q2 - Results - Earnings Call Slides

Aug. 14, 2019 3:43 PM ET | About: Novo Nordisk A/S (NVO) 

Insulet Corporation (PODD)

image312

 

Insulet (PODD) Presents At Canaccord Genuity Growth Conference - Slideshow

Aug. 13, 2019 2:31 PM ET | About: Insulet Corporation (PODD) 

China Biologic Products Holdings, Inc. (CBPO)

image313

 

China Biologic Products Holdings, Inc. 2019 Q2 - Results - Earnings Call Slides

Aug. 7, 2019 12:12 PM ET | About: China Biologic Products Holdings, Inc. (CBPO) .

CRISPR Therapeutics AG (CRSP)

image314

 

CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow

Aug. 13, 2019 2:26 PM ET|2 comments  | About: CRISPR Therapeutics AG (CRSP) 

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

image315

 

Sangamo Therapeutics, Inc. 2019 Q2 - Results - Earnings Call Slides

Aug. 13, 2019 1:47 PM ET | About: Sangamo Therapeutics, Inc. (SGMO) 

EPS of $-0.25 beats by $0.04 Revenue of $35.99M (-20.52% Y/Y) beats by $6.37M

image316

 

Intrexon Corporation 2019 Q2 - Results - Earnings Call Slides

Aug. 9, 2019 6:29 PM ET | About: Intrexon Corporation (XON) 

earnings Call Slides Q2./HY 2019

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

image317

 

Celgene Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 1:34 PM ET | About: Celgene Corporation (CELG) 

Amarin Corporation plc (AMRN)

image318

 

Amarin Corporation plc 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 10:18 AM ET  | About: Amarin Corporation plc (AMRN) 

EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M

image319

 

Veracyte, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 3:06 PM ET | About: Veracyte, Inc. (VCYT) 

Abiomed, Inc. (ABMD)

image320

 

Abiomed, Inc. 2020 Q1 - Results - Earnings Call Slides

Aug. 1, 2019 10:03 AM ET | About: Abiomed, Inc. (ABMD) 

Becton, Dickinson and Company (BDX)

image321

 

Becton, Dickinson and Company 2019 Q3 - Results - Earnings Call Slides

Aug. 6, 2019 10:16 AM ET | About: Becton, Dickinson and Company (BDX) 

Vertex Pharmaceuticals Incorporated (VRTX)

image322

 

Vertex Pharmaceuticals Incorporated 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 4:58 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX) 

earnings Call Slides Q2./HY 2019

Incyte Corporation (INCY)

image323

 Incyte Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:26 AM ET  | About: Incyte Corporation (INCY) 

Merck & Co., Inc. (MRK)

image324

 Merck & Co., Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 10:14 AM ET|1 comment | About: Merck & Co., Inc. (MRK) 

Bayer Aktiengesellschaft (BAYZF)

image325

 Bayer Aktiengesellschaft 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 6:39 AM ET | About: Bayer Aktiengesellschaft (BAYZF) 

Amgen Inc. (AMGN)

image326

 Amgen Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:25 PM ET | About: Amgen Inc. (AMGN) 



 http://investors.amgen.com/static-files/e1393dc2-f372-4dcc-992a-afc36a03b8fa 

Gilead Sciences, Inc. (GILD)

image327

 Gilead Sciences, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 4:57 PM ET|2 comments | About: Gilead Sciences, Inc. (GILD) 

Neurocrine Biosciences, Inc. (NBIX)

image328

Neurocrine Biosciences, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 2:37 PM ET|1 comment | About: Neurocrine Biosciences, Inc. (NBIX) 

earnings Call Slides Q2./HY 2019

Pfizer Inc. (PFE)

image329

 Pfizer Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 12:06 PM ET | About: Pfizer Inc. (PFE) 

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

image330

 Sanofi 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 10:04 AM ET | About: Sanofi (SNY) 

EPS of $9.15 beats by $1.62 Revenue of $3.62B (7.75% Y/Y) beats by $142.47M

image331

 Biogen Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 23, 2019 12:39 PM ET|1 comment | About: Biogen Inc. (BIIB) 

Exact Sciences Corporation (EXAS)

image332

 Exact Sciences Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 2:01 PM ET | About: Exact Sciences Corporation (EXAS) 

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

image333

 Illumina, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:07 AM ET | About: Illumina, Inc. (ILMN) 

Eli Lilly and Company (LLY)

image334

 Eli Lilly and Company 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 10:15 AM ET | About: Eli Lilly and Company (LLY) 

earnings Call Slides Q2./HY 2019

EPS of $0.365 beats by $0.06 Revenue of $5.82B (12.96% Y/Y) beats by $251.68M

image335

 

AstraZeneca PLC 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 10:01 AM ET | About: AstraZeneca PLC (AZN) 

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

image336

 

Seattle Genetics, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 17, 2019 1:58 PM ET  | About: Seattle Genetics, Inc. (SGEN) 

EPS of $1.32 beats by $0.19 Revenue of $825.8M (16.46% Y/Y) beats by $63.51M

image337

 

Varian Medical Systems, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 2:07 PM ET | About: Varian Medical Systems, Inc. (VAR) 

NovoCure Limited (NVCR)

image338

  

NovoCure Limited 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 11:37 AM ET | About: NovoCure Limited (NVCR) 

Alkermes plc (ALKS)

image339

 

Alkermes plc 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 8:19 AM ET | About: Alkermes plc (ALKS) 

Roche Holding AG (RHHBY)

image340

 

Roche Holding AG 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 8:17 AM ET  | About: Roche Holding AG (RHHBY) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

Regeneron Pharmaceuticals, Inc. (REGN)

image341

 Regeneron Pharmaceuticals (REGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 2:57 PM ET | About: Regeneron Pharmaceuticals, Inc. (REGN) 

Celgene Corporation (CELG)

image342

 Celgene (CELG) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 12:43 PM ET | About: Celgene Corporation (CELG) 

Amgen Inc. (AMGN)

image343

 Amgen (AMGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 11:42 AM ET  | About: Amgen Inc. (AMGN) 

BioMarin Pharmaceutical Inc. (BMRN)

image344

 BioMarin Pharmaceutical (BMRN) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 12:45 PM ET  | About: BioMarin Pharmaceutical Inc. (BMRN) 

Illumina, Inc. (ILMN)

image345

 Illumina, Inc. (ILMN) Presents at J.P. Morgan Healthcare Conference - Slide Show

Jan. 7, 2019 8:10 PM ET|9 comments  | About: Illumina, Inc. (ILMN) 

Allergan plc (AGN)

 Allergan (AGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 1:19 PM ET|2 comments | About: Allergan plc (AGN) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

Insulet Corporation (PODD)

image346

 Insulet Corporation (PODD) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 10, 2019 6:17 AM ET  | About: Insulet Corporation (PODD) 

Intrexon Corp (XON)

image347

 Intrexon (XON) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 10, 2019 9:34 AM ET | About: Intrexon Corp (XON) 

PerkinElmer, Inc. (PKI)

image348

 PerkinElmer (PKI) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 10, 2019 9:21 AM ET | About: PerkinElmer, Inc. (PKI) 

ABIOMED, Inc. (ABMD)

image349

ABIOMED (ABMD) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 3:53 PM ET  | About: ABIOMED, Inc. (ABMD) 

GW Pharmaceuticals plc (GWPH)

image350

 GW Pharmaceuticals (GWPH) Presents at Annual 2019 JP Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 2:15 PM ET|2 comments  | About: GW Pharmaceuticals plc (GWPH) 

Varian Medical Systems, Inc. (VAR)

image351

 Varian Medical Systems (VAR) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 1:22 PM ET  | About: Varian Medical Systems, Inc. (VAR) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

CVS Health Corporation (CVS)

image352

 CVS Health (CVS) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 2:16 PM ET | About: CVS Health Corporation (CVS) 

AbbVie Inc. (ABBV)

image353

 AbbVie Inc. (ABBV) Presents at 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 12:14 PM ET|3 comments  | About: AbbVie Inc. (ABBV) 

Bausch Health Companies Inc. (BHC)

image354

 Bausch Health (BHC) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 1:18 PM ET|10 comments  | About: Bausch Health Companies Inc. (BHC)
 

Takeda Pharmaceutical Co., Ltd. (TKPHF) TAK

image355

 Takeda Pharmaceutical (TKPHF) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 10, 2019 12:48 PM ET | About: Takeda Pharmaceutical Co., Ltd. (TKPHF), TAK 

Incyte Corporation (INCY)

image356

 Incyte (INCY) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 2:29 PM ET  | About: Incyte Corporation (INCY) 

Teva Pharmaceutical Industries Limited (TEVA)

image357

 Teva Pharmaceutical (TEVA) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 1:30 PM ET|4 comments  | About: Teva Pharmaceutical Industries Limited (TEVA) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

Neurocrine Biosciences, Inc. (NBIX)

image358

 Neurocrine Biosciences (NBIX) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 2:05 PM ET  | About: Neurocrine Biosciences, Inc. (NBIX) 

NovoCure (NVCR)

image359

 NovoCure (NVCR) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 10, 2019 3:31 PM ET | About: NovoCure (NVCR) 

EXACT Sciences Corporation (EXAS)

image360

 Exact Sciences (EXAS) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 1:08 PM ET  | About: EXACT Sciences Corporation (EXAS) 

Alkermes plc (ALKS)

image361

 Alkermes (ALKS) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 10, 2019 5:56 AM ET | About: Alkermes plc (ALKS) 

Sarepta Therapeutics, Inc. (SRPT)

image362

 Sarepta Therapeutics (SRPT) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 1:13 PM ET|2 comments | About: Sarepta Therapeutics, Inc. (SRPT) 

Enanta Pharmaceuticals, Inc. (ENTA)

image363

 Enanta Pharmaceuticals (ENTA) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 9, 2019 3:51 PM ET | About: Enanta Pharmaceuticals, Inc. (ENTA) 

©2018 MarketsandMarkets Research Private Ltd.

Biomarker Technologies Market

image364

 Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022

Efficacy Testing Market

image365

 Efficacy Testing Market by Product and Service (Consumables, Services), Type (Antimicrobial Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products) - Global Forecast to 2022

Oncology Information System Market

image367

 Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) - Global Forecasts to 2019

Non Invasive Prenatal Testing (NIPT) Market

image368

 Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

Bioinformatics Market

image369

 Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023

©2018 BlackRock, Inc. All Rights Reserved.

image370

Sep 25, 2018 By Bob Miller, Rick Rieder

 An exceptionally strong labor market and reasonably firm inflation
have the Fed monitoring the heat in the U.S. economy. 


image371

  September 2018 - 

BlackRock Investment Institute 

We see a growing disconnect between waning market attention to our top 10 geopolitical risks and the likelihood of some of them escalating. Our global BlackRock Geopolitical Risk Indicator (BGRI) has declined since our last update, suggesting the market’s attention to geopolitical risks overall has edged down. Yet the overall reading masks considerable dispersion, and we have raised the likelihood of three of our risks.Global trade tensions is our focus risk this month as U.S. trade disputes with major trading partners carry on. 

image372

 Sep 19, 2018 -  By Russ Koesterich 

 At $3.5 trillion per year, total healthcare spending (public and private) makes up roughly 20% of the U.S. economy. The nation’s 80 million baby boomers provide a stable source of ongoing revenue growth for healthcare companies throughout the value chain. Demographic tailwinds are widely expected to continue to propel this secular story in the United States. 

image373

 Sep 14, 2018 By Michael Fredericks

 In the United States, we continue to observe above-trend fundamental data, including strong corporate earnings, capital expenditures (business investment) and consumer sentiment. U.S. stocks notably outperformed international markets, with the S&P 500 Index rallying over 3% in August whereas European equities, for instance, were negative. We believe U.S. outperformance will likely persist in the near-term, underscoring our preference for more domestic-oriented assets. 

image374

 Oct 1, 2018

By BlackRock Investment Institute

 We see the steady global expansion rolling on, underpinned by above-trend U.S. growth. Yet the range of potential economic outcomes is widening. Gradual increases in U.S. rates are tightening financial conditions globally, and have contributed to bouts of volatility and sharply depreciating emerging market (EM) currencies. We also take a deep dive into the prospects for EMs after an unexpectedly drawn-out selloff. 

image375

 Oct 8, 2018 By Richard Turnill

 Global equities’ nearly decade-long bull run is stoking anxiety about its ability to power on. One concern: narrow breadth — a fragile state when a small group of stocks is contributing the lion’s share of market returns, buoying the broader index. We see today’s strong equity performance, especially in the U.S., as broad-based and driven by healthy fundamentals and solid earnings momentum. 

© 2018 Grand View Research, Inc. All rights reserved.

image376

 Posted On Sep, 05, 2018

Cancer Biomarkers Market: Increasing demand for rapid and specific cancer diagnosis

 

image377

Posted On Sep, 05, 2018 

Regenerative Medicine: Presence of strong product pipeline coupled with emerging applications in gene therapy projected to drive market


image379

Posted On Sep, 05, 2018

 Biosimilars - A Pioneering Approach To Futuristic Treatments!


image380

   June 2018 

The global genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.7% during the forecast period.

image381

 Published Date: Sep, 2018

Metagenomics Market Size, Share & Trends Analysis Report By Product (Sequencing & Data Analytics), By Technology (Sequencing, Function), By Application (Environmental), And Segment Forecasts, 2018 - 2025

Some of the prominent players operating in this market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup.